###begin article-title 0
Amyloid Oligomer Conformation in a Group of Natively Folded Proteins
###end article-title 0
###begin p 1
Conceived and designed the experiments: YY RM YM YRC TK. Performed the experiments: YY RM. Analyzed the data: YY RM YM YRC TK AT. Wrote the paper: YY RM AT.
###end p 1
###begin p 2
###xml 836 841 <span type="species:ncbi:9606">human</span>
###xml 861 866 <span type="species:ncbi:4932">yeast</span>
###xml 879 885 <span type="species:ncbi:9913">bovine</span>
Recent in vitro and in vivo studies suggest that destabilized proteins with defective folding induce aggregation and toxicity in protein-misfolding diseases. One such unstable protein state is called amyloid oligomer, a precursor of fully aggregated forms of amyloid. Detection of various amyloid oligomers with A11, an anti-amyloid oligomer conformation-specific antibody, revealed that the amyloid oligomer represents a generic conformation and suggested that toxic beta-aggregation processes possess a common mechanism. By using A11 antibody as a probe in combination with mass spectrometric analysis, we identified GroEL in bacterial lysates as a protein that may potentially have an amyloid oligomer conformation. Surprisingly, A11 reacted not only with purified GroEL but also with several purified heat shock proteins, including human Hsp27, 40, 70, 90; yeast Hsp104; and bovine Hsc70. The native folds of A11-reactive proteins in purified samples were characterized by their anti-beta-aggregation activity in terms of both functionality and in contrast to the beta-aggregation promoting activity of misfolded pathogenic amyloid oligomers. The conformation-dependent binding of A11 with natively folded Hsp27 was supported by the concurrent loss of A11 reactivity and anti-beta-aggregation activity of heat-treated Hsp27 samples. Moreover, we observed consistent anti-beta-aggregation activity not only by chaperones containing an amyloid oligomer conformation but also by several A11-immunoreactive non-chaperone proteins. From these results, we suggest that the amyloid oligomer conformation is present in a group of natively folded proteins. The inhibitory effects of A11 antibody on both GroEL/ES-assisted luciferase refolding and Hsp70-mediated decelerated nucleation of Abeta aggregation suggested that the A11-binding sites on these chaperones might be functionally important. Finally, we employed a computational approach to uncover possible A11-binding sites on these targets. Since the beta-sheet edge was a common structural motif having the most similar physicochemical properties in the A11-reactive proteins we analyzed, we propose that the beta-sheet edge in some natively folded amyloid oligomers is designed positively to prevent beta aggregation.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 256 259 256 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Fandrich1">[1]</xref>
###xml 457 460 457 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Kayed1">[2]</xref>
###xml 479 513 479 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Society for Neuroscience Abstracts</italic>
###xml 461 528 461 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Gidalevitz1">[5, Kayed et al., <italic>Society for Neuroscience Abstracts</italic> 2005;35:893.6]</xref>
###xml 1058 1061 1058 1061 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Kayed1">[2]</xref>
###xml 1275 1278 1275 1278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Kayed1">[2]</xref>
Protein misfolding diseases are characterized by the formation of amyloid, which occurs through misfolding promoted by the conversion of a protein from its native to non-native state. Under the appropriate conditions, any proteins can form generic amyloid [1]. The ability of an oligomeric entity in amyloid to seed the polymerization of other proteins indicates that amyloid may disrupt cellular functions by interfering with the folding of other proteins [2]-[5, Kayed et al., Society for Neuroscience Abstracts 2005;35:893.6]. Therefore, it is important to understand the molecular mechanism(s) underlying the seeding function of amyloid oligomers, whose pathogenic significance in protein misfolding diseases have been well supported. Because amyloid oligomers innately tend to aggregate, high-resolution elucidation of their structures through conventional physical techniques has been challenging. Novel insight on the structure of amyloid oligomers was made possible by the development of an anti-amyloid oligomer conformation-dependent antibody, A11 [2]. The fact that various amyloid oligomers are A11 immunopositive suggests that amyloid oligomers share a common structure and implies that various protein-misfolding diseases may have a common pathogenic mechanism [2]. In the present study, we identified proteins that contain the amyloid oligomer conformation by using the A11 antibody as a probe. One group of A11-reactive proteins commonly displayed anti-beta-aggregation activity as opposed to the expected beta-aggregation promoting activity of misfolded amyloid oligomers.
###end p 4
###begin title 5
Results
###end title 5
###begin title 6
Amyloid oligomer conformation in chaperones
###end title 6
###begin p 7
###xml 123 126 123 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Kayed1">[2]</xref>
###xml 264 280 264 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 456 463 456 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 822 831 818 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003235-g001">Figure 1A</xref>
###xml 1140 1143 1136 1139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Hartl1">[6]</xref>
###xml 264 280 <span type="species:ncbi:562">Escherichia coli</span>
###xml 456 463 <span type="species:ncbi:562">E. coli</span>
A11 is an antibody that specifically detects the conformation of amyloid oligomers regardless of their amino acid sequence [2]. To determine whether proteins that contain the amyloid oligomer conformation exist in bacteria, we examined the A11 immunoreactivity of Escherichia coli cell lysates. We chose to examine bacterial proteins because extensive structural information about these proteins already exists in the protein data bank (PDB). We subjected E. coli DH5alpha cell lysates to PAGE analysis. To reduce false-positive signals, we used sample buffer that contained neither SDS nor reducing agents to solubilize the lysates although the disruption of conformation was predicted to some extent during SDS-PAGE. One gel was Western blotted with A11 to identify the molecular weights of A11-immunoreactive proteins (Figure 1A), and another gel was stained with coomassie brilliant blue (CBB). The bands in the CBB-stained gel corresponding to the A11-immunoreactive bands on the immunoblot were analyzed by tandem mass spectrometry (MS-MS). We identified one of these A11-immunoreactive bands to contain GroEL, a bacterial chaperonin [6]. Unlike other proteomics studies that have used sequence-dependent antibodies, in our study, the proteins detected in the cell lysates through this simple approach remain unconfirmed candidates of A11-reactive proteins. Indeed, the conformational specificity of A11 for each protein (purified and native forms) needs to be analyzed, since the cell lysis procedure might have affected protein conformation to unknown degrees.
###end p 7
###begin title 8
Amyloid oligomer conformation in chaperones.
###end title 8
###begin p 9
###xml 4 11 4 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 357 360 341 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A&#8211;G</italic>
###xml 508 509 492 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 1303 1304 1265 1266 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 4 11 <span type="species:ncbi:562">E. coli</span>
(A) E. coli competent cells (strain DH5alpha; TOYOBO, Japan) were freeze-thawed three times by freezing the cells on ice at -180degreesC then thawing them at 37degreesC. The lysates were then mixed with sample buffer lacking SDS and reducing agents and then subjected to PAGE analysis. One gel was immunoblotted with A11 antibody. A11-immunoreactive bands (A-G) were excised from the CBB-stained gel, treated with trypsin, and analyzed by tandem-mass spectrometry. A candidate A11-reactive protein from band B was GroEL. The difference in staining patterns between the A11 immunoblot and CBB-stained gel indicates A11 antibody-binding selectivity. Note also that the proteins in cell lysates reacted with the A11 antibody are not necessarily all natively folded. Purified GroEL (23 microM) was mixed with sample buffer lacking both reducing agents and SDS, and then run on (B) a gel in a regular SDS-containing buffer or (C) a gel in a buffer lacking SDS (native PAGE). Gels were blotted onto a membrane that was subsequently probed with A11 under the same conditions. Note that the mobility of the molecular weight standard is different in (B) and (C). (D) The following solutions (3 microL each) were dot blotted onto a nitrocellulose membrane: 20 microM Abeta40 monomer, 20 microM Abeta40 oligomer, H2O, purified 23 microM GroEL, 37 microM Hsp27, 20 microM Hsp40, 14 microM Hsp70, 12 microM Hsp90, 10 microM Hsp104, and 10 microM Hsc70. GroEL, Hsp27, Hsp40, Hsp90, and Hsc70 were purchased from Stressgen (Canada). Hsp70 was from Sigma (USA). Hsp104 was from ATGen (South Korea). Each protein solution was blotted onto a single membrane that was probed with A11 under the same conditions. The individual dot blots were arranged into a single column.
###end p 9
###begin p 10
###xml 156 165 156 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003235-g001">Figure 1B</xref>
###xml 514 523 514 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003235-g001">Figure 1C</xref>
###xml 596 605 596 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003235-g001">Figure 1D</xref>
###xml 980 989 980 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003235-g001">Figure 1D</xref>
###xml 1462 1465 1447 1450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Kayed1">[2]</xref>
###xml 1484 1518 1469 1503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Society for Neuroscience Abstracts</italic>
###xml 1466 1533 1451 1518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Gidalevitz1">[5, Kayed et al., <italic>Society for Neuroscience Abstracts</italic> 2005;35:893.6]</xref>
###xml 826 831 <span type="species:ncbi:9606">human</span>
###xml 895 900 <span type="species:ncbi:4932">yeast</span>
###xml 913 919 <span type="species:ncbi:9913">bovine</span>
To confirm the A11 immunoreactivity of GroEL, we performed Western analysis on purified GroEL and observed that A11 strongly immunostained monomeric GroEL (Figure 1B). Although the sample buffer used in this PAGE analysis lacked SDS and reducing agents, the running buffer did contain SDS. In true native PAGE, which is performed without SDS, A11 mostly immunostained a high molecular weight band representing a GroEL oligomer complex, which is the expected functionally active form of GroEL in bacterial cytosol (Figure 1C). A11 antibody also strongly immunostained purified GroEL on dot blots (Figure 1D). This enabled us to exclude the possibility that the PAGE processing misfolded GroEL molecules that potentially could react with A11 and lead to false A11 positives. A11 antibody also immunostained purified recombinant human chaperones, including heat shock protein (Hsp) 27, 40, 70, 90; yeast Hsp104; and bovine heat shock cognate (Hsc) 70, albeit with varying intensity (Figure 1D). As expected, A11 antibody immunostained beta-amyloid (Abeta) oligomer prepared from Abeta(1-40) but not monomeric Abeta. These results suggest that certain chaperone structures share a common amyloid oligomer conformation. Among the A11-reactive candidates, we were interested in identifying chaperones that normally display anti-aggregation activity as opposed to proteins, such as misfolded pathogenic amyloid oligomers, that induce beta-aggregation of other proteins [2]-[5, Kayed et al., Society for Neuroscience Abstracts 2005;35:893.6].
###end p 10
###begin title 11
Proteins containing the amyloid oligomer conformation affect Abeta aggregation in opposite ways
###end title 11
###begin p 12
###xml 205 208 193 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-LeVine1">[7]</xref>
###xml 210 219 198 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003235-g002">Figure 2A</xref>
###xml 571 574 550 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-LeVine1">[7]</xref>
###xml 576 587 555 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003235-g002">Figure 2B&#8211;D</xref>
###xml 718 721 694 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Muchowski1">[8]</xref>
###xml 755 758 731 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Evans1">[9]</xref>
###xml 760 764 736 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Wilhelmus1">[10]</xref>
###xml 1099 1102 1066 1069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Hartl1">[6]</xref>
###xml 1190 1202 1154 1166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003235-g002">Figure 2E, F</xref>
###xml 1778 1781 1733 1736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Dobson1">[4]</xref>
###xml 1783 1787 1738 1742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Anfinsen1">[11]</xref>
To confirm the seeding property of pathogenic Abeta oligomer, we assessed the beta-aggregation kinetics of Abeta40 in the presence of preformed Abeta oligomer using a thioflavin T (ThT) fluorescence assay [7] (Figure 2A), and found that Abeta oligomer induced Abeta aggregation in a dose-dependent manner. To determine whether the chaperones we assessed with A11 antibody were functionally active and thus natively folded or misfolded like pathogenic amyloid oligomers, we examined the effects of Hsp27, Hsp70, and Hsp90 on Abeta-aggregation kinetics using the ThT assay [7] (Figure 2B-D). Abeta, a type of amyloid protein observed in Alzheimer's disease (AD), has been pathologically linked to these three chaperones [8]. As with other published studies [9], [10], we found that all three chaperones-Hsp27, Hsp70, and Hsp90-suppressed the beta aggregation of Abeta in a dose-dependent manner to varying degrees. We did not observe fibrillar amyloid structures in Abeta samples incubated with each of these chaperones under an electron microscope (data not shown). To verify this chaperone activity [6], we examined whether the anti-beta-aggregation properties of Hsp was energy dependent (Figure 2E, F). Adding ATP to samples containing Hsp70 or Hsp70/Hsp40 at concentrations that alone do not show anti-beta-aggregation activity caused Hsp70 and Hsp70/Hsp40 to significantly suppress Abeta aggregation. Most of the purified recombinant chaperones used here, including Hsp70 and Hsp40, have tested positive for their ATPase activity. The energy-dependent anti-beta-aggregation activity of these chaperone samples indicates that A11-immunoreactive chaperones are indeed functional; thus, a significant number of chaperone molecules in these purified samples are natively folded [4], [11]. In other words, the native structures of these chaperones possess the amyloid oligomer conformation. Therefore, there are at least two classes of A11-reactive proteins that contain the amyloid oligomer conformation: pathogenic amyloid oligomers that promote beta aggregation and chaperones that suppress beta aggregation.
###end p 12
###begin title 13
Contrasting effects of Abeta oligomer and chaperones on Abeta aggregation.
###end title 13
###begin p 14
###xml 133 134 123 124 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 341 342 318 319 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 542 543 500 501 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 621 622 579 580 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 624 625 582 583 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 653 654 611 612 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 657 658 615 616 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 719 720 670 671 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1004 1005 933 934 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1007 1008 936 937 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1045 1046 966 967 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1049 1050 970 971 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1151 1152 1064 1065 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1154 1155 1067 1068 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1192 1193 1097 1098 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1196 1197 1101 1102 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
(A) Abeta40 (final concentration: 5 microM) dissolved in aCSF was mixed with 0, 0.5, 5, or 50 nM Abeta40 oligomer (i.e., "seed") in H2O. Results from a sample containing only 50 nM Abeta40 oligomer is also shown. ThT fluorescence intensity indicates the level of Abeta aggregation. (B) Abeta40 (final concentration: 10 microM) dissolved in H2O was mixed with 0, 10, 100, or 1000 nM Hsp27 in buffer (1.08 mM Tris-HCl [pH 7.5], 541 microM NaCl, 54.1 microM EDTA, and 54.1 microM DTT). (C) Abeta40 (final concentration: 10 microM) dissolved in H2O was mixed with 0, 10, 100, or 1000 nM Hsp70 in buffer (2.7 mM KCl, 1.5 mM KH2PO4, 137 mM NaCl, and 8.1 mM Na2HPO4). (D) Abeta40 (final concentration: 5 microM) dissolved in H2O was mixed with 0, 5, 50, or 500 nM Hsp90 in buffer (3.9 mM Tris-HCl [pH 7.5], 7.8 mM NaCl, and 78.2 microM DTT). (E) Anti-beta-aggregation activity of Hsp40 and Hsp70. Abeta40 (5 microM) dissolved in aCSF was mixed with either 10 nM Hsp70 in buffer A (15.1 microM KCl, 8.4 microM KH2PO4, 767 microM NaCl, and 45.3 microM Na2HPO4) or a mixture of 10 nM Hsp70 in Buffer A and 10 nM Hsp40 in Buffer B (10.8 microM KCl, 6.0 microM KH2PO4, 548 microM NaCl, and 32.4 microM Na2HPO4) in the presence or absence of 500 microM Mg-ATP. (F) Bar graph showing ThT fluorescence intensity of Abeta samples with or without chaperones after 17 h of incubation. Statistical significance was calculated by using a Student's t-test. *p = 0.035; **p = 0.00046. Data are presented as means+/-SEM.
###end p 14
###begin title 15
Heating affects the amyloid oligomer conformation and anti-beta-aggregation activity of Hsp27
###end title 15
###begin p 16
###xml 144 152 141 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003235-g003">Figure 3</xref>
###xml 327 330 321 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Muchowski1">[8]</xref>
###xml 549 558 537 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003235-g003">Figure 3A</xref>
###xml 649 658 637 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003235-g003">Figure 3B</xref>
###xml 904 913 886 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003235-g003">Figure 3C</xref>
###xml 1435 1439 1411 1415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Ehrnsperger1">[12]</xref>
Next, we examined how heat treatment alters the amyloid oligomer conformation of Hsp27 and the Hsp27-mediated suppression of Abeta aggregation (Figure 3). We assessed Hsp27 because of its strong A11 immunoreactivity on both dot blot and native-PAGE/Western blot analyses, and because of its pathological association with Abeta [8]. We heated Hsp27 dissolved in buffer to 80degreesC for 15 and 30 min and then subjected the sample to native-PAGE followed by Western blotting with A11 antibody. Heat treatment abolished A11 immunoreactivity of Hsp27 (Figure 3A), even though the peptide backbone of Hsp27 was intact (SDS-PAGE of heat-treated samples, Figure 3B). ThT assay of samples containing Abeta and heat-treated Hsp27, however, showed that Hsp27-mediated suppression of Abeta aggregation disappeared concurrently with the reduction of amyloid oligomer conformation resulting from the heat treatment (Figure 3C). The heat-denaturing experiments simply suggested that the conformation-specific binding of A11, and thus the amyloid oligomer conformation-not non-specific interactions-was consistently observed as natively folded Hsp27 prevented beta aggregation. These results certainly did not demonstrate that the A11-reactive domain within Hsp27 is responsible for suppressing Abeta aggregation. Both the structure and functional mechanisms of Hsp27 are unknown. Since the spherical and oligomeric forms of Hsp27 are active states [12], Hsp27 could co-oligomerize with Abeta while suppressing amyloidogenesis. Heat-treated Hsp27 may have also formed amyloid that complexed with Abeta. Taken together, these data identify the amyloid conformation as the generic structural feature of natively folded chaperones directly correlating with the anti-beta-aggregation activity of chaperones.
###end p 16
###begin title 17
Effects of heat treatment on amyloid oligomer conformation in Hsp27 and the anti-beta-aggregation activity of Hsp27.
###end title 17
###begin p 18
###xml 553 556 543 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Muchowski1">[8]</xref>
###xml 558 562 548 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Ehrnsperger1">[12]</xref>
###xml 940 941 920 921 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1357 1360 1310 1313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-LeVine1">[7]</xref>
(A) Western blot of Hsp27 probed with A11 anti-amyloid oligomer conformation-dependent antibody. Hsp27 samples were heat treated at 80degreesC for 15 or 30 min. Heat-treated and untreated Hsp27 samples (10 microM) were mixed with sample buffer lacking SDS and reducing reagents, subjected to native PAGE using 4-20% gels, and separated proteins were immunoblotted with A11 antibody. Note that A11-immunoreactive Hsp27 bands migrated to a high molecular-weight level in native PAGE, because Hsp27 exists as large oligomers having chaperone-like activity [8], [12]. (B) Heat-treated and untreated Hsp27 samples (10 microM) were mixed with sample buffer containing SDS and beta-mercaptoethanol, and then subjected to SDS-PAGE using 4-20% gels. Gels were stained with coomassie brilliant blue (CBB). (C) Abeta-aggregation kinetics of samples containing heat-treated Hsp27. One buffer sample and three Hsp27 samples were diluted 100 times with H2O. Abeta40 (final concentration: 5 microM) dissolved in aCSF was mixed with buffer (54 microM Tris-HCl [pH 7.5], 27 microM NaCl, 2.7 microM EDTA, and 2.7 microM DTT); untreated 50 nM Hsp27; 15-min heat-treated Hsp27; or 30-min heat-treated Hsp27. All samples were incubated in the presence of 10 microM ThT; triplicate measurements were taken every 30 min at excitation and emission wavelengths of 440 nm and 486 nm [7], respectively. Data are presented as means+/-SEM.
###end p 18
###begin title 19
A11 immunoreactivity and anti-beta-aggregation activity in non-chaperone proteins
###end title 19
###begin p 20
###xml 391 395 379 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Schwarzman1">[13]</xref>
###xml 397 401 385 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Stein1">[14]</xref>
###xml 488 497 473 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003235-g004">Figure 4A</xref>
###xml 670 674 640 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Blacker1">[15]</xref>
###xml 764 772 724 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 772 776 732 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Hughes1">[16]</xref>
###xml 778 782 738 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Du1">[17]</xref>
###xml 805 814 765 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003235-g004">Figure 4B</xref>
###xml 888 897 844 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003235-g004">Figure 4C</xref>
###xml 1093 1097 1049 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Reixach1">[18]</xref>
###xml 1297 1300 1250 1253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Kayed1">[2]</xref>
###xml 1319 1353 1272 1306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Society for Neuroscience Abstracts</italic>
###xml 1301 1368 1254 1321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Gidalevitz1">[5, Kayed et al., <italic>Society for Neuroscience Abstracts</italic> 2005;35:893.6]</xref>
###xml 1451 1460 1401 1410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003235-g004">Figure 4A</xref>
###xml 1462 1466 1412 1416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Schwarzman1">[13]</xref>
###xml 1468 1472 1418 1422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Stein1">[14]</xref>
Anti-beta-aggregation activity is not unique to chaperones. Thus, if chaperones with anti-beta-aggregation activity contain the amyloid oligomer conformation, we assumed that other proteins known to suppress Abeta aggregation might also contain the amyloid oligomer conformation. One such protein is transthyretin (TTR), which has been shown to sequester Abeta and prevent amyloid formation [13], [14]. We confirmed the suppressive effect of TTR on Abeta aggregation in our model system (Figure 4A). Another protein with anti-Abeta-aggregation properties is alpha2-macroglobulin (alpha2MG). Although the genetic association between alpha2MG and AD remains controversial [15], the anti-beta-aggregation activity of alpha2MG against Abeta has been reported to occur in vitro[16], [17], as we also observed (Figure 4B). As expected, A11 antibody immunostained dot blots of TTR and alpha2MG (Figure 4C), indicating that both proteins possess the amyloid oligomer conformation. Although TTR is a protein that forms amyloid in pathogenic conditions, its A11 immunoreactivity has never been reported [18]. If a significant number of TTR molecules somehow misfold and bind to A11 in solution, they are more likely to induce or cross-seed Abeta aggregation, as other misfolded pathogenic amyloid oligomers [2]-[5, Kayed et al., Society for Neuroscience Abstracts 2005;35:893.6]. In our experiment, this did not occur. Instead TTR suppressed Abeta aggregation (Figure 4A) [13], [14], indicating that the amyloid oligomer conformation within TTR is not misfolded but is natively folded.
###end p 20
###begin title 21
Dose-dependent suppression of Abeta aggregation by A11-immunoreactive non-chaperone proteins.
###end title 21
###begin p 22
###xml 264 265 247 248 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 519 522 474 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Kayed1">[2]</xref>
###xml 1064 1069 <span type="species:ncbi:9606">human</span>
(A) Abeta40 (final concentration: 5 microM) dissolved in aCSF was mixed with 0, 50, 500, or 5000 nM TTR in 10 mM Tris-HCl (pH 7.4) with 0.9% NaCl. ThT fluorescence indicates the level of Abeta aggregation. (B) Abeta40 (final concentration: 5 microM) dissolved in H2O was mixed with 0, 5, 50, or 500 nM alpha2MG in buffer (1.45 mM Tris-HCl [pH 8.0], 9.4 mM glycine, and 5.8 mM trehalose). (C) Dot blot of 100 microM TTR, 13.8 microM alpha2MG, 17.2 microM DT, and 15.2 microM ETA (3 microl each) probed with A11 antibody [2]. (D) and (E) Abeta40 (final concentration: 5 microM) dissolved in aCSF was mixed with buffer alone; 5, 50, or 500 nM DT; or ETA. For (D), the buffer contained 10 mM Tris-HCl (pH 7.4) and 1 mM EDTA. For (E), the buffer contained 10 mM sodium phosphate (pH 7.5) and 150 mM NaCl. (F) Dot blot of 100 microM pdE (approx. MW: 50 kDa); 10 mM plE (approx. MW: 1000 Da); and 50 microM Abeta40 oligomer (3 microl each) probed with A11, secondary antibody alone without primary antibody, and 4G8 antibody (which reacts to amino acid residues 17-24 of human Abeta). (G) and (H) Abeta40 (final concentration: 5 microM) dissolved in PBS was mixed with buffer alone; 0.05, 0.5, 5 microM pdE; or plE. Data are presented as means+/-SEM.
###end p 22
###begin p 23
###xml 152 156 145 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Blake1">[19]</xref>
###xml 158 162 151 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Jenner1">[20]</xref>
###xml 281 285 274 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Choe1">[21]</xref>
###xml 287 291 280 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Allured1">[22]</xref>
###xml 355 364 348 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003235-g004">Figure 4C</xref>
###xml 469 477 459 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 574 586 561 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003235-g004">Figure 4D, E</xref>
Analysis of the crystal structures of the TTR and alpha2MG receptor-binding domains reveal that both contain a beta sandwich with a jelly-roll topology [19], [20]. The crystal structures of diphtheria toxin (DT) and exotoxin A (ETA) also have a homologous jelly-roll-like topology [21], [22]. As expected, A11 antibody also immunostained both DT and ETA (Figure 4C). Surprisingly, these amyloid oligomer conformation-containing toxins also suppressed Abeta aggregation in vitro in a dose-dependent manner, even though they have no known physiological relationship to Abeta (Figure 4D, E). These results suggest that A11 immunoreactivity is not only found in chaperones but is also found among certain non-chaperone proteins possessing anti-beta-aggregation activity.
###end p 23
###begin p 24
###xml 350 361 341 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003235-g004">Figure 4F&#8211;H</xref>
###xml 499 503 490 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Kimura1">[23]</xref>
Comparative analyses require control experiments. Thus in the present study, we tested whether A11-immunonegative proteins fail to inhibit beta aggregation. Different chain lengths of D-poly glutamic acids (pdE) and L-poly glutamic acids (plE) did not exhibit A11 immunoreactivity or inhibit beta aggregation, instead they promoted beta aggregation (Figure 4F-H). These results support the conformational specificity of A11 antibody binding. Indeed, plE mostly exists as a random coil at neutral pH [23], the same pH we used in our control experiment. These results also suggest that A11 reactivity, and thus amyloid oligomer conformation, is not the only functional determinant of beta-aggregation-promoting activity. Because we did not test the anti-beta-aggregation activity of all purified and folded A11-non-reactive proteins, we could not exclude the possibility that an A11-non-reactive protein possessing anti-beta-aggregation activity exists. For the same reason, our current results cannot exclude the possible existence of A11-reactive folded proteins that do not possess anti-beta-aggregation activity. Therefore, we do not advance the idea that A11 immunoreactivity is a prerequisite for anti-beta-aggregation activity.
###end p 24
###begin title 25
A11 affects GroE-assisted luciferase refolding and Hsp70-decelerated Abeta nucleation
###end title 25
###begin p 26
###xml 453 462 447 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003235-g005">Figure 5A</xref>
To determine whether the A11-binding site plays a functional role in protein folding, we first investigated the effects of A11 antibody on GroEL/ES (GroE)-assisted firefly luciferase refolding. Luciferase samples were heated at 45degreesC for 5 min. After cooling the samples at room temperature for 5 min and adding luciferin substrate, GroEL/ES and ATP facilitated luciferase refolding, which was evident by the increased luminescence in the samples (Figure 5A). Luminescence was not observed in heat-treated samples co-incubated with GroEL/ES and ATP in the presence of A11. This suggests that A11 prevented GroEL/ES-assisted refolding of heat-denatured luciferase. Surprisingly, A11 itself assisted luciferase refolding to a similar extent as GroEL/ES.
###end p 26
###begin title 27
A11-mediated inhibition of GroE-assisted luciferase refolding and Hsp70-mediated decelerated Abeta nucleation.
###end title 27
###begin p 28
###xml 703 704 691 692 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
(A) In a sample of GroE (final concentrations: 1.25 microM GroEL and 2.1 microM GroES) and luciferase (final concentration: 100 nM), about 30% of luciferase activity was recorded relative to the activity of luciferase samples without heat-treatment, indicating that GroE-assisted partial refolding of heat-denatured luciferase had occurred. Luciferase activity was not observed when heat-treated luciferase was co-incubated with both GroE and A11 (final concentration: 0.1 mg/mL). A11 antibody assisted the refolding of luciferase (n = 15 for GroE and n = 6 for GroE/A11 and A11 alone, respectively). Data are presented as means+/-SEM. (B) Three microliters of 250 nM GroEL, 2.5 microM luciferase, and H2O were blotted onto a nitrocellulose membrane. The membrane was incubated either with the A11 antibody in 5% skim milk or with just skim milk. (C) Abeta40 (final concentration: 5 microM) dissolved in aCSF was mixed with or without Hsp70 (final concentration: 75 nM) and A11 (final concentration: 300 nM). All samples were incubated in the presence of 5 microM ThT. Triplicate measurements were taken every 30 min. Average fluorescence values are plotted. Error bars were omitted from the graph for clarity.
###end p 28
###begin p 29
###xml 178 182 178 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Ermolenko1">[24]</xref>
###xml 184 188 184 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Xu1">[25]</xref>
###xml 346 350 343 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Conti1">[26]</xref>
###xml 429 438 426 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003235-g005">Figure 5B</xref>
Antibody-assisted refolding of proteins, including luciferase, has been reported previously in cases in which an antibody specific to a given protein facilitates antigen folding [24], [25]. Therefore, we surmised that the A11-assisted refolding of luciferase we observed might involve A11 binding to luciferase, which also possesses a beta motif [26]. Thus, we tested the A11 immunoreactivity of purified luciferase by dot blot (Figure 5B). The luciferase sample exhibited A11 immunoreactivity that was weaker than that of the positive GroEL control blotted on the same membrane. These results provide a possible explanation for the assisted refolding of luciferase by A11: Like other antibodies having chaperone-like activity, A11 may induce luciferase refolding through specific interactions. If this is the case, then the diminished refolding of luciferase in samples containing both chaperonin and A11 is more likely due to the interaction of A11 with chaperonin rather than the interaction of A11 with luciferase.
###end p 29
###begin p 30
###xml 123 132 117 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003235-g005">Figure 5C</xref>
Next, we examined how A11 affects Hsp70-mediated suppression of Abeta aggregation by assessing Abeta aggregation kinetics (Figure 5C). The presence of Hsp70 decelerated the nucleation of Abeta aggregation. This effect was suppressed by A11, even though elongation was not substantially affected. This result indicates that the A11-binding site on Hsp70 may play a role in inhibiting nucleation but not elongation during Abeta aggregation. Interestingly, A11 alone failed to substantially affect Abeta aggregation at the concentration used. It will be interesting to examine in further detail whether A11 assists or prevents the oligomerization of Abeta and other amyloidogenic proteins. The present results indicate that A11-binding sites on chaperones may be functionally important.
###end p 30
###begin title 31
Deduction of A11-epitope and amyloid oligomer conformation through structural similarity search
###end title 31
###begin p 32
###xml 607 614 604 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
###xml 1060 1063 1054 1057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Kayed1">[2]</xref>
###xml 1156 1164 1150 1158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003235-g006">Figure 6</xref>
###xml 1169 1178 1163 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003235.s001">Figure S1</xref>
###xml 1492 1496 1477 1481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Braig1">[27]</xref>
###xml 1497 1501 1482 1486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Li1">[30]</xref>
###xml 1584 1588 1569 1573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Lee1">[31]</xref>
###xml 1589 1593 1574 1578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Ali1">[33]</xref>
###xml 1720 1724 1702 1706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Schwarzman1">[13]</xref>
###xml 1726 1730 1708 1712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Schwarzman2">[34]</xref>
###xml 1932 1936 1911 1915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Serag1">[35]</xref>
###xml 2231 2235 2198 2202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Richardson1">[36]</xref>
Our analysis of A11 immunoreactivity and anti-beta-aggregation activity of purified proteins led us to identify at least ten A11-reactive folded proteins with reported crystal structures. These included associated protein fragments and corresponding homologues from different species. Information about A11-immunoreactive proteins and their atomic structures may help us deduce the conformation shared by amyloid oligomers. To determine the A11 epitope and thus amyloid oligomer conformation, we searched each of the ten crystal structures for areas sharing the most surface physicochemical properties (see Methods). For the similarity search, we placed two main restrictions according to the known properties of amyloid oligomer conformations. First, the search was limited to only structures having a beta strand, which is a generally accepted basic component of amyloid. Second, the search was limited to only areas that are less influenced by amino acid side chains, because A11 immunoreactivity is conformation dependent not amino-acid-sequence dependent [2]. Areas showing the most similarity are shown in red for each of the ten crystal structures (Figure 6 and Figure S1). All areas were located at the side edge of the beta-sheet conformation, which comprises most of larger beta-structural motifs such as the beta-sandwich motif. Some of the potential A11-binding areas were located at or near the suggested substrate-binding domain of chaperones (e.g., GroEL, Hsp70, Hsc70, Hsp40) [27]-[30], while other potential A11-binding areas were not (e.g., ClpB [Hsp104] and Hsp90) [31]-[33]. The Abeta-binding site of TTR, previously identified through site-directed mutagenesis as well as through molecular modeling [13], [34], partially matched the area proposed here as the A11 epitope. Interestingly, the displacement of this particular terminal beta strand by a conformational change promotes fibril formation of TTR itself [35]. These observations support the hypothesis that the beta-sheet edge, a common feature of the ten crystal structures we assessed, plays a key role in A11-reactive proteins. Indeed, the negative design of the beta-sheet edge supposedly helps natural beta-sheet proteins to avoid beta aggregation [36]. Here, we propose that beta-sheet edge in natively folded amyloid oligomers not only protects proteins from undergoing beta aggregation but also prevents interacting molecules from undergoing beta aggregation. Thus, in some cases this can be considered to be a positive design. How the amyloid oligomer conformation influences protein conformation still needs to be determined in the future. This can be achieved by investigating the detailed molecular interactions between chaperone/chaperone-like proteins and the A11 antibody and between these proteins and amyloidogenic proteins.
###end p 32
###begin title 33
Sites with physicochemical properties of greatest similarity among ten A11-reactive proteins.
###end title 33
###begin p 34
The crystal structures of ten A11-reactive proteins were aligned to identify the areas where the physicochemical properties of solvent-exposed atoms show the highest similarity (red). (A) GroEL [1aon]. (B) alpha2MG [1ayo]. (C) Hsp40 [1c3g]. (D) DnaK (Hsp70) [1dkz]. (E) TTR (prealbumin) [1dvq]. (F) ETA [1ikq]. (G) DT [1mdt]. (H) ClpB (Hsp104) [1qvr]. (I) Hsc70 [1yuw]. (J) Hsp90 [2cg9]. The PDB codes of the structures used in the structural similarity search are shown in square brackets.
###end p 34
###begin title 35
Discussion
###end title 35
###begin p 36
###xml 93 96 93 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Kayed1">[2]</xref>
###xml 381 384 375 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Kayed1">[2]</xref>
###xml 403 437 397 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Society for Neuroscience Abstracts</italic>
###xml 385 452 379 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Gidalevitz1">[5, Kayed et al., <italic>Society for Neuroscience Abstracts</italic> 2005;35:893.6]</xref>
###xml 639 642 633 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Kayed1">[2]</xref>
By using the A11 antibody, an antibody known to detect the conformation of amyloid oligomers [2], we unexpectedly observed the amyloid oligomer conformation in a group of proteins whose folds were functionally characterized as native on the basis of their anti-beta-aggregation activity. This contrasts with the misfolded pathogenic amyloid oligomers that promote beta aggregation [2]-[5, Kayed et al., Society for Neuroscience Abstracts 2005;35:893.6]. Because we propose a novel corollary to the original claim that A11 recognizes a common structure shared by oligomeric intermediates formed by a diverse range of amyloidogenic proteins [2], our results were carefully examined.
###end p 36
###begin p 37
###xml 243 251 243 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003235-g003">Figure 3</xref>
###xml 300 308 300 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003235-g004">Figure 4</xref>
Could the recognition by A11 of the identified proteins be a non-specific effect caused, for example, by a small fraction of partially misfolded A11 antibody? We considered that this was unlikely because heat-denatured Hsp27 did not bind A11 (Figure 3). A11 reacted with some non-chaperone proteins (Figure 4). Moreover, none of the identified A11-immunoreactive proteins bound secondary antibody in samples lacking A11 (data not shown).
###end p 37
###begin p 38
###xml 223 232 217 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003235-g002">Figure 2E</xref>
###xml 255 264 249 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003235-g003">Figure 3C</xref>
###xml 285 296 279 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003235-g004">Figure 4G,H</xref>
###xml 472 481 463 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003235-g005">Figure 5A</xref>
###xml 619 628 607 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003235-g005">Figure 5C</xref>
Could the anti-beta-aggregation activity of the identified proteins be induced by colloidal or crowding effects? We considered this to be unlikely because Hsp70/40 exhibited energy-dependent anti-beta-aggregation activity (Figure 2E). Heat-treated Hsp27 (Figure 3C) and polyglutamate (Figure 4G,H) did not show the anti-beta-aggregation activity. In addition, crowded GroE/A11 mixtures did not facilitate luciferase refolding more than less crowded GroE or A11 solutions (Figure 5A). Along similar lines, crowded Hsp70/A11 mixtures did not enhance anti-beta-aggregation activity more than less crowded Hsp70 solutions (Figure 5C).
###end p 38
###begin p 39
###xml 379 391 376 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003235-g004">Figure 4D, E</xref>
###xml 475 484 466 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003235-g002">Figure 2A</xref>
###xml 676 679 667 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Kayed1">[2]</xref>
###xml 698 732 689 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Society for Neuroscience Abstracts</italic>
###xml 680 747 671 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Gidalevitz1">[5, Kayed et al., <italic>Society for Neuroscience Abstracts</italic> 2005;35:893.6]</xref>
Could A11 be recognizing traces of misfolded amyloidogenic intermediates of these proteins? We considered that this was unlikely because if the contaminating molecules of such misfolded amyloid intermediates were substantially present in the sample, then we would expect the A11-reactive proteins, especially non-chaperone proteins like toxins, not to suppress beta aggregation (Figure 4D, E). Rather, we would expect them to promote beta aggregation as Abeta oligomers did (Figure 2A), because misfolded amyloid oligomers characteristically promote oligomerization and fibrillization of other proteins, a suggested pathogenic mechanism underlying protein misfolding diseases [2]-[5, Kayed et al., Society for Neuroscience Abstracts 2005;35:893.6]. A functional property that was commonly observed in the group of A11-reactive proteins was anti-beta-aggregation activity, which differentiated these proteins from misfolded pathogenic amyloid oligomers, which promote beta-aggregation. Together with the conformation-specific nature of A11 reactivity, this phenomenon led us to conclude that a significant number of molecules in the purified samples were neither misfolded nor unfolded, but were most likely natively folded.
###end p 39
###begin p 40
###xml 178 181 178 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Fandrich1">[1]</xref>
###xml 358 362 358 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Fandrich2">[37]</xref>
###xml 456 460 456 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Kimura1">[23]</xref>
###xml 651 662 648 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003235-g004">Figure 4F&#8211;H</xref>
###xml 794 803 791 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003235-g001">Figure 1A</xref>
###xml 950 957 947 954 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1137 1140 1134 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Kayed1">[2]</xref>
###xml 1506 1509 1503 1506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Kayed1">[2]</xref>
###xml 1822 1825 1819 1822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Kayed1">[2]</xref>
Does the notion of a "common structure" mean anything if it so diverse it encompasses the folded and misfolded proteins? Under the right conditions, any protein can form amyloid [1]. The formation of amyloid structures by poly amino acids supports the premise that amyloid formation occurs independent of specific side-chain contacts or amino acid sequences [37]. Although plE forms amyloid at pH 4.1, it exists mostly as a random coil at physiological pH [23]. Indeed, plE dissolved in a neutral pH buffer showed neither A11 immunoreactivity nor anti-beta-aggregation activity, which is consistent with the conformational specificity of A11 binding (Figure 4F-H). The difference in the staining patterns in immunoblots probed with A11 and in CBB-stained gels of bacterial cell lysate samples (Figure 1A) indicates that A11 does not bind just any protein. Not all A11-reactive proteins in the bands were necessarily natively folded or retained their in vivo conformation, since lysing the cells can significantly affect the conformation of some proteins. We believe that A11 specificity does exist, as demonstrated in the original study [2]. It is most important to note, however, that the specificity of A11 is completely different from that of other antibodies that recognize specific amino acid sequences in that A11 reactivity depends on the three-dimensional conformation of a protein since A11 specifically binds oligomeric intermediates but not unfolded monomers or fibers of amyloidogenic proteins [2]. Thus, A11 reactivity is independent of an antigen's amino acid sequence, because A11 specifically binds oligomeric intermediates formed by a diverse range of amyloidogenic proteins. The conformational-dependent binding specificity of A11 also implies that the amyloid oligomer represents a generic conformation [2]. On the basis of this particular generic property of the A11 antibody, we believe that A11 antibody is also capable of binding a group of natively folded proteins, as we observed in the present study.
###end p 40
###begin p 41
###xml 214 222 214 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003235-g005">Figure 5</xref>
###xml 592 596 592 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Prusiner1">[38]</xref>
###xml 597 601 597 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Ashcroft1">[41]</xref>
###xml 754 758 754 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Wetzel1">[39]</xref>
What is the functional significance of having an amyloid oligomer conformation within natively folded proteins? Function-blocking experiments clarified the functional importance of A11-binding sites on chaperones (Figure 5). To further tackle this issue structurally, we took a computational approach. A functional property shared by pathogenic amyloid oligomers and chaperones is that both affect the conformation of unfolded proteins. This property might depend on the structural plasticity that is shared by amyloid and the substrate-binding domain of chaperonin, called the apical domain [38]-[41]. The structural plasticity of amyloid is partially based on its polymorphism, the ability of one polypeptide to form aggregates of different structures [39]. Indeed, the polymorphic nature of amyloid sets it apart from other globular folded proteins with unique structures. Thus, it is unlikely that the amyloid oligomer conformation is represented by a unique structure.
###end p 41
###begin p 42
###xml 124 127 124 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Kayed1">[2]</xref>
###xml 129 133 129 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Wetzel1">[39]</xref>
###xml 313 321 313 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003235-g006">Figure 6</xref>
###xml 326 335 326 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003235.s001">Figure S1</xref>
###xml 444 448 444 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Ferguson1">[42]</xref>
###xml 449 453 449 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Jahn2">[46]</xref>
###xml 649 653 643 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Kameda1">[43]</xref>
###xml 654 658 648 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Jahn2">[46]</xref>
###xml 766 770 754 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Richardson1">[36]</xref>
###xml 1044 1048 1029 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Braig1">[27]</xref>
###xml 1135 1138 1117 1120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Dobson1">[4]</xref>
###xml 1140 1143 1122 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Hartl1">[6]</xref>
###xml 1427 1431 1400 1404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-DebBurman1">[47]</xref>
###xml 1433 1437 1406 1410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Stockel1">[48]</xref>
###xml 1651 1655 1621 1625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Li1">[30]</xref>
###xml 1657 1661 1627 1631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Douglas1">[49]</xref>
On the other hand, amyloid also exhibits isomorphism, the ability of different polypeptides to display similar morphologies [2], [39]. Taking advantage of this property, we searched for areas containing similar physicochemical properties on the surfaces of the crystal structures of A11-reactive folded proteins (Figure 6 and Figure S1). Our analysis results were consistent with the proposed structures of amyloid protofilaments or precursors [42]-[46]. Although the non-native amyloid precursor of beta2-microglobulin is highly native-like, its edge strands contain perturbations that normally protect beta-sandwich proteins from self-association [43]-[46]. Structurally, the edges of a completely regular beta-sandwich motif are inherently beta-aggregation prone [36]. Coincidentally, our structural similarity search revealed that the beta-sheet edge of GroEL was located in the apical domain. A pioneering study on GroEL suggested that chaperonins act by stabilizing non-native intermediates against off-pathway misfolding and aggregation [27]. Because beta-sheet structures are primarily formed through main-chain hydrogen bonds [4], [6], the induction of beta-strand formation in a substrate through the beta-sheet edge in the apical domain of GroEL may normally function to prevent non-specific side-chain contacts and thus non-specific aggregation, but in certain cases promote beta aggregation as reported previously [47], [48]. We consider this idea to be speculative but consistent with the formation of beta-strands by non-native substrates in a complex structure with Hsp40, and consistent with Hsp40-dependent amyloid assembly in cells [30], [49].
###end p 42
###begin p 43
###xml 353 357 353 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Anfinsen1">[11]</xref>
###xml 584 587 584 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Fandrich1">[1]</xref>
###xml 589 592 589 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Kayed1">[2]</xref>
###xml 594 597 594 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Dobson1">[4]</xref>
Finally, we would like to mention evolutionary aspects of 'native' amyloid oligomers. The presence of the amyloid oligomer conformation within a natively folded protein indicates that the folding observed in this type of conformation is based on amino acid sequence, which is encoded in that particular protein's gene according to Anfinsen's hypothesis [11]. On the other hand, the unprecedented diversity of proteins containing amyloid oligomer conformations also indicates that the folding in these conformations may be caused by something else, especially in pathogenic conditions [1], [2], [4]. In evolution, aggregative properties of some proteins may have pressured the selection of anti-aggregation properties in some genes as a preventive measure. On the basis of the generic anti-aggregation characteristics of certain A11-reactive folded proteins, such as the chaperone family, we hypothesize that (1) the amyloid oligomer conformation has evolved over time as a means to prevent non-specific protein aggregations, and that (2) based on the structural commonality, amyloidogenic proteins may sporadically deviate from this system of preventing protein aggregation in some conditions such as aging in the extended life span of humanity today that has not been caught up by evolution.
###end p 43
###begin title 44
Materials and Methods
###end title 44
###begin title 45
Immunoblot (Western blot and dot blot)
###end title 45
###begin p 46
###xml 317 320 307 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Kayed1">[2]</xref>
###xml 428 434 <span type="species:ncbi:9986">rabbit</span>
###xml 456 461 <span type="species:ncbi:10090">mouse</span>
Separated proteins by SDS-PAGE were transferred onto nitrocellulose membranes by using a wet system at 4degreesC. Alternatively, 3 microL of sample solution was dot-blotted onto membranes. After being blocked with milk, the blotted membrane was probed with anti-amyloid oligomer antibody A11 (1:1000; Biosource, USA) [2] or 4G8 (1:1000; Signet, USA). A11 and 4G8 antibody immunoreactivity were detected with HRP-conjugated anti-rabbit IgG (1:2500) or anti-mouse IgG (1:5000), respectively, followed by ECL. A replicated membrane probed with the secondary antibody alone did not display signals. Each panel displaying an immunoblot was from a single membrane and thus a single experiment. For presentation purposes, the squares containing each dot blot were arranged in a single column or row for figures.
###end p 46
###begin title 47
Abeta oligomer preparation
###end title 47
###begin p 48
###xml 52 55 49 52 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Kayed1">[2]</xref>
Abeta oligomer was prepared as described previously [2]. Briefly, lyophilized Abeta40 peptide (Peptide Institute, Japan) was dissolved in 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) (Wako, Japan) on ice and aliquoted to be frozen until use. Abeta was spin-vacuumed just prior to the experiment; dissolved in HFIP solution (final concentration: 10% (v/v) HFIP); and kept at room temperature under constant stirring. After 2 days, the tube was transferred to and maintained at 4degreesC.
###end p 48
###begin title 49
Thioflavin T (ThT) assay
###end title 49
###begin p 50
###xml 134 135 128 129 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 218 219 212 213 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 230 231 224 225 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 244 245 238 239 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 247 248 241 242 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 261 262 255 256 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 876 879 847 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-LeVine1">[7]</xref>
Lyophilized Abeta40 peptide was first dissolved in HFIP on ice. Most of the HFIP was vacuum evaporated before Abeta was dissolved in H2O; PBS; or artificial cerebrospinal fluid (aCSF: 124 mM NaCl, 2.5 mM KCl, 2 mM CaCl2, 2 mM MgSO4, 1.25 mM NaH2PO4, 26 mM NaHCO3, and 10 mM glucose). Solubilized Abeta40 (5 microM) was mixed with a protein dissolved in a respective buffer. Note that different buffer conditions resulted in different aggregation kinetics of Abeta. ThT (10 microM unless otherwise noted) was added to each solution to assess the formation of beta-sheet structures. Samples were incubated at 37degreesC in 96-well plates; triplicate measurements were taken every 30 min with an ARVO multilabel spectrofluorometer (PerkinElmer, USA). Plates were shaken for 10 sec prior to every measurement. Excitation and emission wavelengths were 440 and 486 nm, respectively [7]. In each experiment, triplicate wells containing protein sample at each concentration without Abeta were made. Results from the measurement of these wells were not included in the figures because the values were significantly smaller than those of wells with Abeta.
###end p 50
###begin title 51
Luciferase refolding assay
###end title 51
###begin p 52
###xml 106 107 102 103 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 463 464 445 446 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 543 544 521 522 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 564 565 538 539 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 776 777 706 707 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1069 1070 989 990 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Twenty microliters of 250 nM luciferase (Sigma) in 100 mM Tris-HCl (pH 7.4) and 5 microL of 20 mM DTT in H2O were mixed in each well of a 96-well plate. For heat treatment, plates were sealed and placed in an incubator maintained at 45degreesC. After 5 min, the plates were taken out and kept at room temperature for 5 min. Next, 2.5 microL of 40 mM DTT (Nacalai Tesque), samples representing four different conditions, and 2.5 microL of 80 mM Mg-ATP (Sigma) in H2O were added to each well. The four samples were as follows: (1) 15 microL of H2O; (2) 5 microL of H2O, 5 microL of 12.5 microM GroEL, and 5 microL of 21 microM GroES; (3) 5 microL of 1 mg/mL A11, 5 microL of 12.5 microM GroEL, and 5 microL of 21 microM GroES; and (4) 5 microL of 1 mg/mL A11, and 10 microL of H2O. The plate was incubated at 30degreesC for 1 h. As soon as 5 microL of 2 mM luciferin (Nacalai Tesque) dissolved in 100 mM Tris-HCl (pH 7.4) was added to each well, the luminescence was measured with an ARVO multilabel spectrofluorometer (PerkinElmer). The average luminescence value from H2O-incubated wells was subtracted from the luminescence value measured from other wells. The percentage of luminescence recorded in each well was calculated, taking as 100% the average value measured from wells that were not heat treated. The percentages determined for each condition were averaged and defined as percent (%) luciferase activity. GroE represents the combination of both GroEL and GroES.
###end p 52
###begin title 53
Structural similarity search
###end title 53
###begin p 54
###xml 232 239 229 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003235-t001">Table 1</xref>
###xml 342 346 339 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Bush1">[50]</xref>
###xml 963 964 960 961 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Ten PDB files of A11-immunoreactive proteins were retrieved. In the preliminary search, 214 potential sites on the surfaces of ten structures were detected among the areas where the main beta-sheet chain was exposed to the surface (Table 1). Atoms in these sites were first classified into six physicochemical types using the PATTY algorithm [50]. Structural alignment was carried out by aligning the spatial coordinates of atoms at every two sites and identifying pairs of atoms of the same physicochemical type. We then calculated similarity scores for these aligned structures. Twenty-three sites with relatively high similarity scores were determined using a clustering algorithm. For each structure, we selected sites having the highest similarity score. We then constructed a figure by performing multiple structure alignments on the ten sites having the highest similarity scores. Surface atoms were determined by calculating accessible surface areas (>0 A2) at 1.4 A of probe atoms. The atoms were clustered using the single-linkage clustering algorithm with a cutoff value of 4 A. Clusters formed by less than four atoms were removed. Surface atoms that existed within 4 A from atoms of the remaining clusters were included. Each cluster was defined as a single site.
###end p 54
###begin title 55
Potential surface sites on ten A11-reactive proteins in which the main beta-sheet chain is exposed to the surface.
###end title 55
###begin title 56
Similarity score
###end title 56
###begin p 57
###xml 242 246 242 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003235-Bush1">[50]</xref>
###xml 256 258 256 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AT</italic>
###xml 269 271 269 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AT</italic>
###xml 296 298 296 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AT</italic>
###xml 326 328 326 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AT</italic>
###xml 345 347 345 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AT</italic>
###xml 370 372 370 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AT</italic>
###xml 638 639 638 639 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 639 640 639 640 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 639 640 639 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>i</sub></italic>
###xml 649 650 649 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</italic>
###xml 747 748 747 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</italic>
###xml 771 773 771 773 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ij</sub>
###xml 770 773 770 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d<sub>ij</sub></italic>
###xml 775 776 775 776 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 774 776 774 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d<sub>c</sub></italic>
###xml 791 792 789 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">j</italic>
###xml 804 807 802 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATx</italic>
###xml 830 831 828 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">j</italic>
###xml 868 869 866 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</italic>
###xml 880 881 878 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 908 910 906 908 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ij</sub>
###xml 907 910 905 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d<sub>ij</sub></italic>
###xml 947 948 945 946 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</italic>
###xml 958 959 956 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">j</italic>
###xml 983 984 981 982 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 982 984 980 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d<sub>c</sub></italic>
###xml 1082 1084 1080 1082 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ij</sub>
###xml 1081 1084 1079 1082 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">s<sub>ij</sub></italic>
###xml 1088 1089 1086 1087 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sub>
###xml 1087 1089 1085 1087 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T<sub>C</sub></italic>
###xml 1090 1091 1088 1089 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</italic>
###xml 1093 1094 1091 1092 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">j</italic>
###xml 1109 1110 1107 1108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</italic>
###xml 1115 1116 1113 1114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">j</italic>
###xml 1135 1136 1133 1134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 1141 1142 1139 1140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 1163 1164 1161 1162 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sub>
###xml 1162 1164 1160 1162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T<sub>C</sub></italic>
###xml 1165 1166 1163 1164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</italic>
###xml 1167 1168 1165 1166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">j</italic>
Each atom located on a structure's surface was given a feature vector. The feature vector describes the local physicochemical environment of a surface atom. Atoms were first classified into six physicochemical types using the PATTY algorithm [50]: cation (AT1), anion (AT2), hydrogen-bond donor (AT3), hydrogen-bond acceptor (AT4), hydrophobic (AT5), and none of these (AT6). An atom that was both a hydrogen-bond donor and an acceptor ('polar' atom, according to the PATTY algorithm) was treated as 0.5 donor and 0.5 acceptor. The feature vectors were defined for each atom according to this atom-type classification. The feature vector Ci of atom i was defined as:in which the summation was over all the solvent-accessible atoms (including atom i) of the protein,  if dij/dc</=1, and atom j is of type ATx; otherwise, . If atom j is both a donor and an acceptor and x = 3 or 4, a = 0.5; otherwise, a = 1. dij is the distance (in A) between atom i and atom j. The parameter values dc = 3.2 were used. The similarity between each pair of atoms from the two regions was assessed by sij = TC(i, j), where atoms i and j were from regions a and b, respectively; and TC(i,j) is the Tanimoto coefficient:
###end p 57
###begin p 58
###xml 28 29 28 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
###xml 62 63 62 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 68 69 68 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 71 72 71 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
###xml 81 83 77 79 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ij</sub>
###xml 80 83 76 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">s<sub>ij</sub></italic>
###xml 89 90 85 86 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sub>
###xml 88 90 84 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N<sub>a</sub></italic>
###xml 92 93 88 89 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sub>
###xml 91 93 87 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N<sub>b</sub></italic>
###xml 103 105 99 101 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ij</sub>
###xml 102 105 98 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">s<sub>ij</sub></italic>
###xml 128 129 124 125 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sub>
###xml 127 129 123 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N<sub>a</sub></italic>
###xml 135 136 131 132 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sub>
###xml 134 136 130 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N<sub>b</sub></italic>
###xml 173 174 169 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 179 180 175 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 312 313 308 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
Finally, a similarity score S was defined for the two regions a and b: S = Sigmasij/min{Na,Nb}, where sij is defined as above; Na and Nb are the numbers of atoms of regions a and b, respectively; and the summation was over all atom pairs in the alignment except for those pairs of different atom types. Possible S values ranged from 0 to 1, where 1 represents the maximum similarity.
###end p 58
###begin title 59
Supporting Information
###end title 59
###begin p 60
Sites having the most similar physicochemical properties in the molecular structures of ten A11-reactive proteins. Because the aligned site in 1aon was hidden from view at the viewing angle we used for the other structures, only 1aon is shown from a different angle from other molecules. (A) GroEL [1aon]. (B) alpha2MG [1ayo]. (C) Hsp40 [1c3g]. (D) DnaK (Hsp70) [1dkz]. (E) TTR (prealbumin) [1dvq]. (F) ETA [1ikq]. (G) DT [1mdt]. (H) ClpB (Hsp104) [1qvr]. (I) Hsc70 [1yuw]. (J) Hsp90 [2cg9].
###end p 60
###begin p 61
(8.92 MB TIF)
###end p 61
###begin p 62
Click here for additional data file.
###end p 62
###begin p 63
We thank Professor C. G. Glabe and his colleagues, Professor M. Taiji, and Takashima laboratory members for great advice and critical discussions. We are grateful for the support of BSI's Research Resources Center for MS-MS analysis.
###end p 63
###begin title 64
References
###end title 64
###begin article-title 65
Amyloid fibrils from muscle myoglobin.
###end article-title 65
###begin article-title 66
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis.
###end article-title 66
###begin article-title 67
Prion detection by an amyloid seeding assay.
###end article-title 67
###begin article-title 68
Protein folding and misfolding.
###end article-title 68
###begin article-title 69
Progressive disruption of cellular protein folding in models of polyglutamine diseases.
###end article-title 69
###begin article-title 70
Molecular chaperones in the cytosol: from nascent chain to folded protein.
###end article-title 70
###begin article-title 71
Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution.
###end article-title 71
###begin article-title 72
Modulation of neurodegeneration by molecular chaperones.
###end article-title 72
###begin article-title 73
Heat shock proteins 70 and 90 inhibit early stages of amyloid beta-(1-42) aggregation in vitro.
###end article-title 73
###begin article-title 74
Small heat shock proteins inhibit amyloid-beta protein aggregation and cerebrovascular amyloid-beta protein toxicity.
###end article-title 74
###begin article-title 75
Principles that govern the folding of protein chains.
###end article-title 75
###begin article-title 76
Binding of non-native protein to Hsp25 during heat shock creates a reservoir of folding intermediates for reactivation.
###end article-title 76
###begin article-title 77
Transthyretin sequesters amyloid-beta protein and prevents amyloid formation.
###end article-title 77
###begin article-title 78
###xml 29 44 <span type="species:ncbi:10090">transgenic mice</span>
Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways.
###end article-title 78
###begin article-title 79
alpha2-macroglobulin is genetically associated with Alzheimer disease.
###end article-title 79
###begin article-title 80
alpha2-macroglobulin associates with beta-amyloid peptide and prevents fibril formation.
###end article-title 80
###begin article-title 81
###xml 122 125 <span type="species:ncbi:10116">rat</span>
alpha2-macroglobulin attenuates beta-amyloid peptide 1-40 fibril formation and associated neurotoxicity of cultured fetal rat cortical neurons.
###end article-title 81
###begin article-title 82
Tissue damage in the amyloidoses: Transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture.
###end article-title 82
###begin article-title 83
Protein-DNA and protein-hormone interactions in prealbumin: a model of the thyroid hormone nuclear receptor?
###end article-title 83
###begin article-title 84
Crystal structure of the receptor-binding domain of alpha2-macroglobulin.
###end article-title 84
###begin article-title 85
The crystal structure of diphtheria toxin.
###end article-title 85
###begin article-title 86
###xml 27 49 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Structure of exotoxin A of Pseudomonas aeruginosa at 3.0-angstrom resolution.
###end article-title 86
###begin article-title 87
Direct observation of the multistep helix formation of poly-L-glutamic acids.
###end article-title 87
###begin article-title 88
Antibodies as specific chaperones.
###end article-title 88
###begin article-title 89
Monoclonal antibodies assisting refolding of firefly luciferase.
###end article-title 89
###begin article-title 90
Crystal structure of firefly luciferase throws light on a superfamily of adenylate-forming enzymes.
###end article-title 90
###begin article-title 91
The crystal structure of the bacterial chaperonin GroEL at 2.8 A.
###end article-title 91
###begin article-title 92
Structural analysis of substrate binding by the molecular chaperone DnaK.
###end article-title 92
###begin article-title 93
Structural basis of interdomain communication in the Hsc70 chaperone.
###end article-title 93
###begin article-title 94
###xml 29 34 <span type="species:ncbi:4932">yeast</span>
The crystal structure of the yeast Hsp40 Ydj1 complexed with its peptide substrate.
###end article-title 94
###begin article-title 95
The structure of ClpB: a molecular chaperone that rescues proteins from an aggregated state.
###end article-title 95
###begin article-title 96
###xml 79 95 <span type="species:ncbi:562">Escherichia coli</span>
The crystal structure of the carboxy-terminal dimerization domain of htpG, the Escherichia coli Hsp90, reveals a potential substrate binding site.
###end article-title 96
###begin article-title 97
Crystal structure of an Hsp90-nucleotide-p23/Sba1 closed chaperone complex.
###end article-title 97
###begin article-title 98
Interaction of transthyretin with amyloid beta-protein: binding and inhibition of amyloid formation.
###end article-title 98
###begin article-title 99
Arrangement of subunits and ordering of beta-strands in an amyloid sheet.
###end article-title 99
###begin article-title 100
Natural beta-sheet proteins use negative design to avoid edge-to-edge aggregation.
###end article-title 100
###begin article-title 101
The behaviour of polyamino acids reveals an inverse side chain effect in amyloid structure formation.
###end article-title 101
###begin article-title 102
Prions.
###end article-title 102
###begin article-title 103
Plasticity of amyloid fibrils.
###end article-title 103
###begin article-title 104
The crystal structure of a GroEL/peptide complex: plasticity as a basis for substrate diversity.
###end article-title 104
###begin article-title 105
Structural plasticity and noncovalent substrate binding in the GroEL apical domain. A study using electrospay ionization mass spectrometry and fluorescence binding studies.
###end article-title 105
###begin article-title 106
General structural motifs of amyloid protofilaments.
###end article-title 106
###begin article-title 107
###xml 81 82 78 79 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Nuclear magnetic resonance characterization of the refolding intermediate of beta2-microglobulin trapped by non-native prolyl peptide bond.
###end article-title 107
###begin article-title 108
Amyloid formation under physiological conditions proceeds via a native-like folding intermediate.
###end article-title 108
###begin article-title 109
A native to amyloidogenic transition regulated by a backbone trigger.
###end article-title 109
###begin article-title 110
The yin and yang of protein folding.
###end article-title 110
###begin article-title 111
Chaperone-supervised conversion of prion protein to its protease-resistant form.
###end article-title 111
###begin article-title 112
Chaperonin-mediated de novo generation of prion protein aggregates.
###end article-title 112
###begin article-title 113
Chaperone-dependent amyloid assembly protects cells from prion toxicity.
###end article-title 113
###begin article-title 114
PATTY: A Programmable Atom Typer and Language for Automatic Classification of Atoms in Molecular Databases.
###end article-title 114
###begin p 115
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 115
###begin p 116
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was partly supported by Grant-in-Aid for Scientific Research on Priority Areas (Research on Pathomechanisms on Brain Disorders) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 116

